Amplitude
  • MAGAZINE
    • Subscribe
    • Current Issue
    • Archives
    • Living With Amplitude
      • Adaptive Living
      • Amputee to Amputee
      • Arts & Culture
      • Education
      • Featured
      • Getting Support
      • Giving Support
      • Health & Medicine
      • Money Matters
      • Relationships
      • Science & Technology
      • Sports & Recreation
      • Transportation & Mobility
      • More Amplitude
  • NEWSLETTER
  • RESOURCES
    • Guide to Living With Limb Loss
    • Amputee Resource Directory
  • ABOUT US
    • Contact Us
    • Advertiser Information
    • Privacy Policy
    • Cookie Policy
    • Cancellation Policy
  • SUBSCRIBE
No Result
View All Result
  • MAGAZINE
    • Subscribe
    • Current Issue
    • Archives
    • Living With Amplitude
      • Adaptive Living
      • Amputee to Amputee
      • Arts & Culture
      • Education
      • Featured
      • Getting Support
      • Giving Support
      • Health & Medicine
      • Money Matters
      • Relationships
      • Science & Technology
      • Sports & Recreation
      • Transportation & Mobility
      • More Amplitude
  • NEWSLETTER
  • RESOURCES
    • Guide to Living With Limb Loss
    • Amputee Resource Directory
  • ABOUT US
    • Contact Us
    • Advertiser Information
    • Privacy Policy
    • Cookie Policy
    • Cancellation Policy
  • SUBSCRIBE
No Result
View All Result
Amplitude

FDA Warns Companies That Sell Illegal Cancer Treatments

May 4, 2017
0

The U.S. Food and Drug Administration (FDA) posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat, or cure cancer. The products are marketed and sold without FDA approval, most commonly on websites and social media platforms.

“Consumers should not use these or similar unproven products because they may be unsafe and could prevent a person from seeking an appropriate and potentially life-saving cancer diagnosis or treatment,” said Douglas W. Stearn, director of the Office of Enforcement and Import Operations in the FDA’s Office of Regulatory Affairs. “We encourage people to remain vigilant whether online or in a store, and avoid purchasing products marketed to treat cancer without any proof they will work. Patients should consult a healthcare professional about proper prevention, diagnosis, and treatment of cancer.”

It is a violation of the Federal Food, Drug, and Cosmetic Act to market and sell products that claim to prevent, diagnose, treat, mitigate, or cure diseases without first demonstrating to the FDA that they are safe and effective for their labeled uses. The illegally sold products cited in the warning letters include a variety of product types, such as pills, topical creams, ointments, oils, drops, syrups, teas, and diagnostics (such as thermography devices). They include products marketed for use by humans or pets that make illegal, unproven claims regarding preventing, reversing, or curing cancer; killing/inhibiting cancer cells or tumors; or other similar anti-cancer claims.

The FDA has requested responses from the 14 companies stating how the violations will be corrected. Failure to correct the violations promptly may result in legal action, including product seizure, injunction, and/or criminal prosecution.

As part of the FDA’s effort to protect consumers from cancer health fraud, the FDA has issued more than 90 warning letters in the past ten years to companies marketing hundreds of fraudulent products that make cancer claims on websites, social media, and in stores. Although many of these companies have stopped selling the products or making fraudulent claims, numerous unsafe and unapproved products continue to be sold directly to consumers due in part to the ease with which companies can move their marketing operations to new websites. The FDA continues to monitor and take action against companies promoting and selling unproven treatments in an effort to minimize the potential dangers to consumers and to educate consumers about the risks.

The FDA encourages healthcare professionals and consumers to report adverse reactions associated with these or similar products to the agency’s MedWatch program (www.fda.gov/Safety/MedWatch/HowToReport/default.htm).

Tags: Health & MedicineMore
Previous Post

Penn State Student’s Prosthetic Foot Design Advances in 3D Challenge

Next Post

Stretching May Reduce Walking Pain in PAD Patients

Next Post

Stretching May Reduce Walking Pain in PAD Patients


Subscribe Today

Recent Posts

  • 22 Ways to Find a Job as an Amputee
  • Paralympic Veteran Scout Bassett Makes Her Own Luck
  • FAQ: How Would a Government Shutdown Affect Amputees?
  • Amputee Pilots Discover Peace, Freedom in the Skies
  • Paid Market Research Study Seeks Participants

201 East 4th Street
Loveland, CO 80537
303-255-0843
©2023 Amplitude Media Group

Today’s amputees are living more dynamic lives than ever before. Amplitude Magazine tells their stories.

About Us
Privacy Policy
Subscribe

FOLLOW US

Facebook Twitter Instagram Linkedin

No part of this electronic publication/website may be reproduced in any form or by any means without prior written permission from Amplitude Media Group.

No Result
View All Result
  • MAGAZINE
    • Subscribe
    • Current Issue
    • Archives
    • Living With Amplitude
      • Adaptive Living
      • Amputee to Amputee
      • Arts & Culture
      • Education
      • Featured
      • Getting Support
      • Giving Support
      • Health & Medicine
      • Money Matters
      • Relationships
      • Science & Technology
      • Sports & Recreation
      • Transportation & Mobility
      • More Amplitude
  • NEWSLETTER
  • RESOURCES
    • Guide to Living With Limb Loss
    • Amputee Resource Directory
  • ABOUT US
    • Contact Us
    • Advertiser Information
    • Privacy Policy
    • Cookie Policy
    • Cancellation Policy
  • SUBSCRIBE

Amplitude